US$ 23.05
glp-1 antagonist drugs glp-1_analogs [TUSOM GLP-1 Receptor Agonists | New
Description
Learn what GLP-1 agonists and antagonists are and how they work

However, no direct link has been found between GLP-1R agonists and higher pulmonary aspiration risk

GLP-1 receptor agonists are medications used to manage obesity and type 2 diabetes

A comprehensive phase 3 program is ongoing to evaluate efficacy, safety, and cardiovascular/renal outcomes in people with obesity and/or T2D

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

Obesity management: Used widely for weight loss, even in non-diabetic individuals
